📰 Based Regimens News
Based Regimens News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Based Regimens. Real-time updates on events, politics, business and more.
June 29, 2023
Eiger BioPharmaceuticals Inc (NASDAQ: EIGR) announced it would focus its development efforts on advancing avexitide in 
June 29, 2023
Prioritizing resources to advance avexitide in hyperinsulinemic hypoglycemia indicationsActive discussions underway with potential partners to advance late-stage virology programsReduction in workforce executed to align with focus on avexitide; ext...
March 16, 2023
/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...
November 3, 2022
/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...
October 12, 2022
First presentation of RSV Older Adult vaccine candidates pivotal phase III efficacy and safety data New data showing Shingrix... | October 12, 2022
May 28, 2022
U.S. Food and Drug Administration Approves Two Opdivo® (nivolumab)-Based Regimens as First-Line Treatments for Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma
October 4, 2021
Breaking news headlines about HIV, linking to 1,000s of sources around the world, on NewsNow: the one-stop shop for breaking news